BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19008714)

  • 1. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
    Kaschina E; Schrader F; Sommerfeld M; Kemnitz UR; Grzesiak A; Krikov M; Unger T
    J Hypertens; 2008 Dec; 26(12):2361-73. PubMed ID: 19008714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT
    Lange C; Sommerfeld M; Namsolleck P; Kintscher U; Unger T; Kaschina E
    Hypertension; 2018 Sep; 72(3):e20-e29. PubMed ID: 29987108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
    Rinaldi B; Di Filippo C; Capuano A; Donniacuo M; Sodano L; Ferraraccio F; Rossi F; D'Amico M
    Diabetes Obes Metab; 2012 Apr; 14(4):320-8. PubMed ID: 22050607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
    Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.
    Zhang Q; Huang JH; Xia RP; Duan XH; Jiang YB; Jiang Q; Sun WJ
    J Surg Res; 2011 May; 167(2):e385-93. PubMed ID: 21392796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
    Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.
    Fujiwara Y; Shiraya S; Miyake T; Yamakawa S; Aoki M; Makino H; Nishimura M; Morishita R
    Int J Mol Med; 2008 Dec; 22(6):703-8. PubMed ID: 19020766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
    Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
    Fouad AA; Qureshi HA; Al-Sultan AI; Yacoubi MT; Al-Melhim WN
    Pharmacology; 2010; 85(3):158-67. PubMed ID: 20150754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis.
    Nagy N; Melchior-Becker A; Fischer JW
    Basic Res Cardiol; 2010 Jan; 105(1):29-38. PubMed ID: 19701787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.
    Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
    J Pharm Pharmacol; 2010 Dec; 62(12):1776-83. PubMed ID: 21054405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms.
    Huffman MD; Curci JA; Moore G; Kerns DB; Starcher BC; Thompson RW
    Surgery; 2000 Sep; 128(3):429-38. PubMed ID: 10965315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm.
    Matsumoto S; Kamide K; Banno F; Inoue N; Mochizuki N; Kawano Y; Miyata T
    Hypertens Res; 2010 Dec; 33(12):1244-9. PubMed ID: 20882024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
    Nagashima A; Watanabe R; Ogawa M; Suzuki J; Masumura M; Hishikari K; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):158-64. PubMed ID: 22561360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
    Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
    Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.